Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1 ‐deficient mice
Brain and Behavior · 2023
DOI: 10.1002/brb3.3142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2023. Verfasst von Danielle Santana-Coelho und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Neuroscience, Baylor University, Waco, Texas, USA. Hauptthemen laut MEDLINE: Fragile X Messenger Ribonucleoprotein 1, Illness Behavior. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Objectives
Fragile X syndrome is the main monogenetic cause of intellectual disability and autism. Alterations in the immune system are commonly found in these developmental disorders. We and others have demonstrated that Fmr1 mutant mice present an altered response to immune stimuli. However, whether this altered immune response can influence the Fmr1 mutant behavioral outcomes in response to inflammation has not been fully investigated. Materials and methods In the current study, we examine the behavioral sickness response of male wildtype and knockout mice to the innate immune stimulus lipopolysaccharide (LPS) (0.1 mg/kg) to determine if Fmr1 mutants have altered sickness behavior. We used an enzyme‐linked immunosorbent assay (ELISA) to measure changes in the cytokine interleukin‐6 (IL‐6) to determine that inflammation was induced in the mice. Sickness behavior was assessed in a wheel‐running paradigm, and a tail suspension test was used to assess the depressive‐like phenotype that follows sickness behavior in response to LPS.
Results
The ELISA using blood serum confirmed a significant increase in IL‐6 in mice that were treated with LPS. Treated Fmr1 mutants exhibited decreased distance traveled in the wheel running after LPS administration, similar to treated controls. Another cohort of animals treated with LPS were tested in the tail suspension test and exhibited no alterations in immobility time in response to LPS.
Conclusion
Together, our data suggest that Fmr1 mutant mice do not have altered sickness behavior in response to a low dose of LPS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychology and Neuroscience, Baylor University, Waco, Texas, USA.
- Institute of Biomedical Studies, Baylor University, Waco, Texas, USA.
- Department of Biology, Baylor University, Waco, Texas, USA.
ORCID-Profile: D Greg Sullens, Joaquin N Lugo
Förderung
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Santana-Coelho, D., Hodges, S. L., Quintero, S. I., Womble, P. D., Sullens, D. G., Narvaiz, D. A., Herrera, R., Sekeres, M. J., & Lugo, J. N. (2023). Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1 ‐deficient mice. Brain and Behavior. https://doi.org/10.1002/brb3.3142
Vancouver
Santana-Coelho D, Hodges SL, Quintero SI, Womble PD, Sullens DG, Narvaiz DA, et al. Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1 ‐deficient mice. Brain and Behavior. 2023. doi:10.1002/brb3.3142
BibTeX
@article{SantanaCoelho2023,
author = {Santana-Coelho, Danielle and Hodges, Samantha L and Quintero, Saul I and Womble, Paige D and Sullens, D Greg and Narvaiz, David A and Herrera, Rebecca and Sekeres, Melanie J and Lugo, Joaquin N},
title = {Lipopolysaccharide‐induced sickness behavior is not altered in male Fmr1 ‐deficient mice},
journal = {Brain and Behavior},
year = {2023},
doi = {10.1002/brb3.3142}
}
EUVIMED